STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket
STERIS plc STE reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of $2.74, up 13.7% from the year-ago quarter's figure. The figure surpassed the Zacks Consensus Estimate by 5.8%.
The adjustment excludes the impacts of certain non-recurring charges, such as the amortization of acquired intangible assets and acquisition and integration-related charges.
The company's GAAP EPS was $1.48, down 3.9% from the year-ago level of $1.54.
Full-year fiscal 2025 adjusted EPS was $9.22, up 12.4% from the year-ago quarter's figure. The bottom line surpassed the Zacks Consensus Estimate by 1.4%.
Following the earnings announcement, STE stock rose 1.8% in after-market trading yesterday.
Revenues of $1.48 billion from continuing operations increased 4.2% year over year. The figure missed the Zacks Consensus Estimate by 0.1%.
Organic revenues at constant exchange rate or CER rose 6% year over year.
Full-year fiscal 2025 revenues of $5.46 billion from continuing operations increased 6.2% year over year. The figure matched the Zacks Consensus Estimate.
The company operates under three segments — Healthcare, Applied Sterilization Technologies ('AST') and Life Sciences.
Revenues at Healthcare rose 5% year over year to $1.10 billion (up 6% on a CER organic basis). While consumable revenues improved 6% and service revenues increased 13%, these were partially offset by a 4% decline in capital equipment revenues. Our model expected Healthcare segment revenues to improve 4.1% in the fiscal fourth quarter.
Revenues at AST improved 9% to $273.9 million (up 10% on a CER organic basis). This performance reflected 6% growth in service revenues and an increase in capital equipment revenues. Our model anticipated a 9% improvement in the segment's quarterly revenues.
Revenues from the Life Sciences segment decreased 7% to $149.5 million (flat year over year on a CER organic basis). The decline was due to the divestiture of the CECS business. This performance reflected 8% growth in consumable revenues, offset by a 16% decline in capital equipment revenues and a 21% drop in service revenues. Our model projected a year-over-year decline of 1.5% for the segment's revenues. (See the Zacks Earnings Calendar to stay ahead of market-making news).
The gross profit in the reported quarter was $641.2 million, up 10% from the prior-year level. The gross margin expanded 224 basis points (bps) year over year to 43.3% despite a 0.3% increase in the cost of revenues.
STERIS witnessed an 8% year-over-year rise in selling, general and administrative expenses. The figure amounted to $333.9 million. Research and development expenses rose 0.8% to $27.7 million. Adjusted operating expenses totaled $361.6 million, up 7.4% year over year. The adjusted operating margin expanded 153 bps to 18.9%.
STERIS exited fiscal 2025 with cash and cash equivalents of $171.7 million compared with $207 million at the end of fiscal 2024.
STERIS plc price-consensus-eps-surprise-chart | STERIS plc Quote
Cumulative net cash flow from operating activities at the end of the fiscal fourth quarter was $1.15 billion compared with $973.2 million in the year-ago period. Further, the company has a five-year annualized dividend growth rate of 9.31%.
STERIS provided its fiscal 2026 projection.
It expects revenues from continuing operations to increase approximately 6-7%. The Zacks Consensus Estimate is pegged at $5.78 billion, implying 5.9% growth from fiscal 2025.
Constant currency organic revenues are also expected to improve approximately 6-7%.
Adjusted EPS is expected to be in the range of $9.90-$10.15. The Zacks Consensus Estimate for the metric is pegged at $9.94.
STERIS ended fourth-quarter fiscal 2025 on a mixed note, wherein earnings beat estimates but revenues missed the same. Barring the Life Sciences segment, all other business segments experienced growth during the quarter. The ongoing growth momentum is driven by solid improvement in global procedure volumes and a diversified customer base. Meanwhile, performance in Life Sciences was dented by the divestiture of the CECS business.
The expansion of both margins bodes well for the stock.
STE currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks from the broader medical space are AngioDynamics ANGO, Integer Holdings Corporation ITGR and Phibro Animal Health PAHC.
AngioDynamics, currently sporting a Zacks Rank #1 (Strong Buy), reported a third-quarter fiscal 2025 adjusted EPS of 3 cents against the Zacks Consensus Estimate of a loss of 13 cents. Revenues of $72 million beat the Zacks Consensus Estimate by 2%. You can see the complete list of today's Zacks #1 Rank stocks here.
ANGO has an estimated fiscal 2026 earnings growth rate of 27.8% compared with the S&P 500 composite's 10.5%. The company surpassed earnings estimates in each of the trailing four quarters, the average surprise being 70.9%.
Integer Holdings, sporting a Zacks Rank #1 at present, posted a first-quarter 2025 adjusted EPS of $1.31, which outpaced the Zacks Consensus Estimate by 3.1%. Revenues of $437.4 million surpassed the Zacks Consensus Estimate by 1.3%.
ITGR has an estimated long-term earnings growth rate of 20.8% compared with the industry's 14.3%. The company's earnings surpassed estimates in three of the trailing four quarters and missed on one occasion, the average surprise being 2.8%.
Phibro Animal Health, currently carrying a Zacks Rank #1, reported a third-quarter fiscal 2025 adjusted EPS of 63 cents, which surpassed the Zacks Consensus Estimate by 21.1%. Revenues of $347.8 million missed the Zacks Consensus Estimate by 0.7%.
PAHC has an estimated long-term earnings growth rate of 26% compared with the industry's 15.8%. The company's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 30.6%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AngioDynamics, Inc. (ANGO) : Free Stock Analysis Report
STERIS plc (STE) : Free Stock Analysis Report
Phibro Animal Health Corporation (PAHC) : Free Stock Analysis Report
Integer Holdings Corporation (ITGR) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
New Strong Buy Stocks for June 5th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Pegasystems PEGA: This company which is a leading provider of Customer Relationship Management software that enables transaction-intensive organizations to manage a broad array of customer interactions, has seen the Zacks Consensus Estimate for its current year earnings increasing 8.4% over the last 60 days. Pegasystems Inc. price-consensus-chart | Pegasystems Inc. Quote Telenor TELNY: This company which is a leading telecommunications company in Norway, and among the most advanced telecommunications markets in the world, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days. Telenor ASA price-consensus-chart | Telenor ASA Quote GDEV Inc. GDEV: This gaming and entertainment powerhouse which is focused on growing and enhancing its portfolio of studios, has seen the Zacks Consensus Estimate for its current year earnings increasing 32.1% over the last 60 days. GDEV Inc. price-consensus-chart | GDEV Inc. Quote OP Bancorp OPBK: This banking company which provides commercial banking services to retail and institutional customers, has seen the Zacks Consensus Estimate for its current year earnings increasing 15.1% over the last 60 days. OP Bancorp price-consensus-chart | OP Bancorp Quote Deutsche Bank DB: This largest bank in Germany which offers a wide variety of investment, financial and related products and services, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.2% over the last 60 day. Deutsche Bank Aktiengesellschaft price-consensus-chart | Deutsche Bank Aktiengesellschaft Quote You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Deutsche Bank Aktiengesellschaft (DB) : Free Stock Analysis Report Pegasystems Inc. (PEGA) : Free Stock Analysis Report Telenor ASA (TELNY) : Free Stock Analysis Report OP Bancorp (OPBK) : Free Stock Analysis Report GDEV Inc. (GDEV) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Comfort Systems (FIX) Rises Higher Than Market: Key Facts
The most recent trading session ended with Comfort Systems (FIX) standing at $510.52, reflecting a +2.28% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a gain of 1.03% for the day. Meanwhile, the Dow experienced a rise of 1.05%, and the technology-dominated Nasdaq saw an increase of 1.2%. Coming into today, shares of the heating, ventilation and air conditioning company had gained 13.66% in the past month. In that same time, the Construction sector gained 3.58%, while the S&P 500 gained 5.27%. Analysts and investors alike will be keeping a close eye on the performance of Comfort Systems in its upcoming earnings disclosure. The company is expected to report EPS of $4.44, up 18.72% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $1.92 billion, up 6.06% from the year-ago period. In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $18.93 per share and a revenue of $7.65 billion, indicating changes of +29.66% and +8.83%, respectively, from the former year. Investors should also take note of any recent adjustments to analyst estimates for Comfort Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 1.72% increase. Currently, Comfort Systems is carrying a Zacks Rank of #2 (Buy). Looking at valuation, Comfort Systems is presently trading at a Forward P/E ratio of 26.37. This indicates a discount in contrast to its industry's Forward P/E of 31.16. The Building Products - Air Conditioner and Heating industry is part of the Construction sector. With its current Zacks Industry Rank of 69, this industry ranks in the top 29% of all industries, numbering over 250. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Don't forget to use to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Comfort Systems USA, Inc. (FIX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Costamare (CMRE) Rises Higher Than Market: Key Facts
Costamare (CMRE) closed the most recent trading day at $9.15, moving +2.75% from the previous trading session. This change outpaced the S&P 500's 1.03% gain on the day. At the same time, the Dow added 1.05%, and the tech-heavy Nasdaq gained 1.2%. The shipping company's stock has climbed by 14.4% in the past month, exceeding the Transportation sector's gain of 5.11% and the S&P 500's gain of 5.27%. The investment community will be paying close attention to the earnings performance of Costamare in its upcoming release. The company is expected to report EPS of $0.67, down 12.99% from the prior-year quarter. It is also important to note the recent changes to analyst estimates for Costamare. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook. Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 16.05% higher. Costamare presently features a Zacks Rank of #3 (Hold). From a valuation perspective, Costamare is currently exchanging hands at a Forward P/E ratio of 3.16. This signifies a discount in comparison to the average Forward P/E of 8.8 for its industry. The Transportation - Shipping industry is part of the Transportation sector. With its current Zacks Industry Rank of 172, this industry ranks in the bottom 31% of all industries, numbering over 250. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize to follow all of these stock-moving metrics, and more, in the coming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Costamare Inc. (CMRE) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
